Goldman Sachs Asset Management, a private equity arm of Goldman Sachs, led a $140m Series D2 financing round in InferVision, a medical artificial intelligence provider specializing in the clinical application of AI and deep learning technologies. "While healthcare has undergone significant evolution, the application of AI technologies to accelerate medical diagnosis stands out as one of the most compelling opportunities to benefit and innovate for a large addressable market in the future. We look forward to helping InferVision achieve this dynamic vision that could have a profound impact on healthcare," Xinyi Feng, Goldman Sachs Asset Management Managing Director.